What is patent?
What is expected from patentee as an obligation to the state?
What are the conditions to be satisfied by an invention to be
patentable?
How is invention defined in the Indian Patent Act which can qualify for grant of a patent?
How is invention defined in the Indian Patent Act which can qualify for grant of a patent?
What are the types of inventions which are not patentable in India?
When should an application for a patent be filed?
Can a published or disclosed invention be patented?
What is considered as the date of patent?
What is the term of a patent in the Indian system?
When should an application for a patent be filed?
Can a published or disclosed invention be patented?
What is considered as the date of patent?
What is the term of a patent in the Indian system?
How
does one keep a patent in force for the full patent term?
What are the essential patent documents to be generated and submitted by a potential patentee?
What are the criteria for naming inventors in an application for patent?
What is the nature of information needed while consulting a patent attorney?
What is opposition under the Indian Patents Act 1970?
What are the essential patent documents to be generated and submitted by a potential patentee?
What are the criteria for naming inventors in an application for patent?
What is the nature of information needed while consulting a patent attorney?
What is opposition under the Indian Patents Act 1970?
What is the cost of filing a patent application in India?
What is the distinction between a patented invention and know how?
Is a patent granted in one country enforceable in other countries?
What is 'mail box' provision?
What is an EMR?
Does India have provision for grant of EMR?
What is industrial property?
What is the Paris Convention?
What are the principal features of the Paris Convention?
What is the meaning of national treatment under the Paris Convention?
What do you understand by the right of priority and what is its significance?
What is implied by importation in relation to working of a patent under the Convention?
Is there a provision for compulsory license in the Paris Convention?
Is there any relationship between the Paris Convention and the TRIPS Agreement?
What are the other advantages of joining the Paris Convention?
What is the Budapest Treaty?
Are there any differences in the filing of patent applications in respect of microbiological inventions and other inventions?
What is the system for protecting microbiological inventions and microorganisms?
What is patent cooperation treaty (PCT)?
Who coordinates the activities of PCT ?
What is the need for PCT ?
How are patent applications under PCT handled?
What is the meaning of delayed processing of the application by the national phase or the regional phase?
What is the benefit of the delayed processing?
Which is the appropriate office in India in relation to international applications?
Will an international application designating India be treated as an application for grant of patent under the 1970 Act?
What is the cost of filing a PCT application?
Where do you pay the fees and in which currency?
Is there any system for protecting new plant variety?
What is UPOV?
What is the criteria for deciding protection of a plant varieties?
Does India have any law for protecting new plant varieties?
What is the distinction between a patented invention and know how?
Is a patent granted in one country enforceable in other countries?
What is 'mail box' provision?
What is an EMR?
Does India have provision for grant of EMR?
What is industrial property?
What is the Paris Convention?
What are the principal features of the Paris Convention?
What is the meaning of national treatment under the Paris Convention?
What do you understand by the right of priority and what is its significance?
What is implied by importation in relation to working of a patent under the Convention?
Is there a provision for compulsory license in the Paris Convention?
Is there any relationship between the Paris Convention and the TRIPS Agreement?
What are the other advantages of joining the Paris Convention?
What is the Budapest Treaty?
Are there any differences in the filing of patent applications in respect of microbiological inventions and other inventions?
What is the system for protecting microbiological inventions and microorganisms?
What is patent cooperation treaty (PCT)?
Who coordinates the activities of PCT ?
What is the need for PCT ?
How are patent applications under PCT handled?
What is the meaning of delayed processing of the application by the national phase or the regional phase?
What is the benefit of the delayed processing?
Which is the appropriate office in India in relation to international applications?
Will an international application designating India be treated as an application for grant of patent under the 1970 Act?
What is the cost of filing a PCT application?
Where do you pay the fees and in which currency?
Is there any system for protecting new plant variety?
What is UPOV?
What is the criteria for deciding protection of a plant varieties?
Does India have any law for protecting new plant varieties?
A patent in an exclusive right granted by a
country to the owner of an invention to make, use, manufacture and market the
invention, provided the invention satisfies certain conditions stipulated in
the law. Exclusivity of right implies that no one else can make, use,
manufacture or market the invention without the consent of the patent holder.
This right is available only for a limited period of time. However, the use or
exploitation of a patent may be affected by other laws of the country which has
awarded the patent.
These laws may relate to health, safety, food,
security etc. Further, existing patents in similar area may also come in the
way. A patent in the law is a property right and hence, can be gifted,
inherited, assigned, sold or licensed. As the right is conferred by the State,
it can be revoked by the State under very special circumstances even if the
patent has been sold or licensed or manufactured or marketed in the meantime.
The patent right is territorial in nature and inventors/their assignees will
have to file separate patent applications in countries of their interest, along
with necessary fees, for obtaining patents in those countries.
A patentee must disclose the invention in a
patent document for anyone to practice it after the expiry of the patent or
practice it with the consent of the patent holder during the life of the
patent.
An invention must satisfy the following three
conditions of :
(i)
Novelty (ii) Inventiveness (Non-obviousness) (iii) Usefulness
Novelty : An invention will be
considered novel if it does not form a part of the global state of the art.
Information appearing in magazines, technical journals, books, newspapers etc.
constitute the state of the art. Oral description of the invention in a
seminar/conference can also spoil novelty. Novelty is assessed in a global
context. An invention will cease to be novel if it has been disclosed in the
public through any type of publications anywhere in the world before filing a
patent application in respect of the invention. Prior use of the invention in
the country of interest before the filing date can also destroy the novelty.
Novelty is determined through extensive literature and patent searches. It
should be realized that patent search is essential and critical for
ascertaining novelty as most of the information reported in patent documents
does not get published any where else.
Inventiveness
(Non-obviousness) : A patent application involves an inventive step if the
proposed invention is not obvious to a person skilled in the art i.e., skilled
in the subject matter of the patent application. The prior art should not point
towards the invention implying that the practitioner of the subject matter
could not have thought about the invention prior to filing of the patent
application. Inventiveness cannot be decided on the material contained in
unpublished patents. The complexity or the simplicity of an inventive step does
not have any bearing on the grant of a patent. In other words a very simple
invention can qualify for a patent. If there is an inventive step between the
proposed patent and the prior art at that point of time, then an invention has
taken place. A mere 'scintilla' of invention is sufficient to found a valid
patent.
Usefulness: An invention must
possess utility for the grant of patent No valid patent can be granted for an
invention devoid of utility.
Invention means a new product
or process involving an inventive step and capable of Industrial
application.
Inventive step means a feature that makes the invention not obvious to a person skilled in the art
Capable of Industrial application means that the invention is capable of being made or used in an industry
However, inventions claiming substance intended for use, or capable of being used, as food or as medicine or drug or relating to substances prepared or produced by chemical processes (including alloys, optical glass, semiconductors and inter-metallic compounds) are not patentable. Only process claims are allowed in such cases.
Meaning of chemical process would also include the biochemical, biotechnological and microbiological process.
Inventive step means a feature that makes the invention not obvious to a person skilled in the art
Capable of Industrial application means that the invention is capable of being made or used in an industry
However, inventions claiming substance intended for use, or capable of being used, as food or as medicine or drug or relating to substances prepared or produced by chemical processes (including alloys, optical glass, semiconductors and inter-metallic compounds) are not patentable. Only process claims are allowed in such cases.
Meaning of chemical process would also include the biochemical, biotechnological and microbiological process.
An invention may satisfy the condition of
novelty, inventiveness and usefulness but it may not qualify for a patent under
the following situations:
i.
an invention which is frivolous or which claims anything obviously
contrary to well established natural laws;
ii.
an invention the primary or intended use or commercial
exploitation of which could be contrary to public order or morality or which
causes serious prejudice to human , animal or plant life or health or to the
environment;
iii.
the mere discovery of scientific principle or the formulation of
an abstract theory or discovery of any living thing or non-living substance
occurring in nature;
iv.
the mere discovery of any new property or new use for a known substance
or of the mere use of a known process, machine or apparatus unless such known
process results in a new product or employs at least one new reactant;
v.
a substance obtained by mere admixture resulting only in the
aggregation of the properties of the components thereof or a process for
producing such substance;
vi.
the mere arrangement or re-arrangement or duplication of known
devices each functioning independently of one another in a known way;
vii.
a method of agriculture or horticulture;
viii.
any process for medicinal, surgical, curative, prophylactic,
diagnostic, therapeutic or other treatment of human beings or any process for a
similar treatment of animals to render them free of disease or to increase
their economic value or that of their products;
ix.
plants and animals in whole or any part thereof other than
microorganisms but including seeds, varieties and species and essentially
biological processes for production or propagation of plants and animals;
x.
mathematical or business method or a computer program per se algorithms
xi.
a literary, dramatic, musical or artistic work or any other
aesthetic creation whatsoever including cinematographic works and television
productions;
xii.
a mere scheme or rule or method of performing mental act or method
of playing game;
xiii.
a presentation of information
xiv.
topography of integrated circuits
xv.
an invention which, in effect, is traditional knowledge or which
is an aggregation or duplication of known properties of traditionally known
component or components
xvi.
inventions relating to atomic energy
Filing of an application for a patent should be
completed at the earliest possible date and should not be delayed. An
application filed with provisional specification, disclosing the essence of the
nature of the invention helps to register the priority by the applicant. Delay
in filing an application may entail some risks like (i) other inventors might
forestall the first inventor by applying for a patent for the said invention
(ii) there may be either an inadvertent publication of the invention by the
inventor himself/herself or by others independently of him/her.
No, publication of an invention in any form by
the inventor before filing of a patent application would disqualify the
invention to be patentable. Hence, inventors should not disclose their inventions
before filing the patent application. The invention should be considered for
publication after a patent application has been filed. Thus, it can be seen
that t11ere is no contradiction between publishing an inventive work and filing
of patent application in respect of the invention.
The date of patent is the date of filing the
application for patent (whether provisional or complete). The term of the
patent is counted from this date.
Term of the patent is 20 years from the date of
filling for all types of inventions
A patent has to be maintained by paying the
maintenance fees every year. If the maintenance fees is not paid, the patent
will cease to remain in force and the invention becomes open to public. Anyone
can then utilize the patent without the danger of infringing the patent.
There are two types of patent documents usually
known as patent specification, namely
(i)
Provisional Specification and (ii) Complete Specification
Provisional
Specification
A provisional specification is usually filed to
establish priority of the invention in case the disclosed invention is only at
a conceptual stage and a delay is expected in submitting full and specific
description of the invention. Although, a patent application accompanied with
provisional specification does not confer any legal patent rights to the
applicants, it is, however, a very important document to establish the earliest
ownership of an invention. The provisional specification is a permanent and
independent scientific cum legal document and no amendment is allowed in this.
No patent is granted on the basis of a provisional specification. It has to be
a followed by a complete specification for obtaining a patent for the said
invention. Complete specification must be submitted within 12 months of filing
the provisional specification. This period can be extended by 3 months. It is
not necessary to file an application with provisional specification before the
complete specification. An application with complete specification can be filed
right at the first instance.
Complete
Specification
Submission of complete specification is
necessary to obtain a patent The contents of a complete specification would
include the following
1. Title of the invention.
2. Field to which the
invention belongs .
3. Background of the
invention including prior art giving drawbacks of the known inventions &
practices.
4. Complete description of
the invention along with experimental results.
5. Drawings etc. essential
for understanding the invention.
6. Claims, which are
statements, related to the invention on which legal proprietorship is being
sought. Therefore the claims have to be drafted very carefully.
The naming of inventors is normally decided on
the basis of the following criteria:
i.
All persons who contribute towards development of patentable
features of an invention should be named inventor(s).
ii.
All persons, who have made intellectual contribution in achieving
the final results of the research work leading to a patent, should be named
inventor(s).
iii.
A person who has not contributed intellectually in the development
of an invention is not entitled to be included as an inventor.
iv.
A person who provides ideas needed to produce the ‘germs of the
invention’ need not himself / herself carry out the experiments, constructs the
apparatus with his/her own hands or make the drawings himself/herself. The
person may take the help or others. Such person who have helped in conducting
the experiments, constructing apparatus or making the drawings or models
without providing any intellectual inputs are not entitled to be named
inventors.
Quite often difficulties are experienced in deciding the names of inventors. To avoid such a situation, it is very essential that all scientists engaged in research should keep factual, clear and accurate recorded of daily work done by them in the form of diary. The pages in the diary should be consecutively numbered and the entries made be signed both by the scientists and the concerned leader.
Quite often difficulties are experienced in deciding the names of inventors. To avoid such a situation, it is very essential that all scientists engaged in research should keep factual, clear and accurate recorded of daily work done by them in the form of diary. The pages in the diary should be consecutively numbered and the entries made be signed both by the scientists and the concerned leader.
As an inventor one should share the complete
invention with a patent attorney in the same manner as a patient confides in a
doctor. A s a doctor may not be able to write a correct prescription without
knowing the details of the disease/problem, a patent attorney may not be able
to draft a good specification in the absence of details about the invention.
Following points should be kept in mind while discussing with the attorney:
i.
Provide complete details of the invention including failures, if
any, on the way to the invention.
Do not feel bad if attorney asks you questions like where did you get the idea from or did you copy the idea from somewhere or are you keeping other inventors working with you on the inventorship or have you published the invention or disclosed it in a seminar/conference or have you displayed the invention in an exhibition? A patent document is a techno-legal document, hence all precautions are to be taken right from the first step. Provides right answers and you may even show your laboratory note book/log book to the attorney. This will help the attorney / agent to explain the inventive step in a precise manner and draft a good specification and associated claims.
Do not feel bad if attorney asks you questions like where did you get the idea from or did you copy the idea from somewhere or are you keeping other inventors working with you on the inventorship or have you published the invention or disclosed it in a seminar/conference or have you displayed the invention in an exhibition? A patent document is a techno-legal document, hence all precautions are to be taken right from the first step. Provides right answers and you may even show your laboratory note book/log book to the attorney. This will help the attorney / agent to explain the inventive step in a precise manner and draft a good specification and associated claims.
ii.
Explain the central theme of the invention and novelty,
inventiveness and utility of the invention.
iii.
Share all the prior art documents in your possession with the
attorney.
iv.
If you have developed an improved version of your competitor's
product/process, admit it and be totally honest. This would help the attorney
in drafting precise claims and avoid excessive claims, which might be struck
down immediately or at a later date.
v.
A detailed description of the best way of putting the invention
into practical use, results of your tests and trials, etc., including all
failures and defects should be given to the attorney.
vi.
Alternative ways of using the invention, and the substitutes or
parts of it i.e., will one chemical compound do as well as any other in the
process?
vii.
It may be worth drafting the patent widely enough to cover less
satisfactory alternatives as well so as to prevent rivals from marketing a less
satisfactory competing product which because of its defects might bring the
whole genre of product into disrepute or which may be cheap.
viii.
Both after an initial search and during the course of the filing
and grant of a patent application, it is important to respond quickly and
accurately to queries which the patent attorney may have. Thus the client
should keep the patent attorney informed of any new developments in the field
of invention carried by the patentee or some one else.
After the Patent Office has examined an application
and found it in order forgrant of a patent, it publishes the title pf the
invention, name of the inventor(s) and the applicant(s), abstract of the
invention, drawings and claims in the Gazette of India, Part III Section 2, for
interested parties to oppose the grant of the patent. An application for
opposition may be filed at the concerned Patent Office branch within four
months of the date of the issue of the concerned gazette. An extension of one
month is possible; a request for extension has to be made within the first four
months. Typed or photocopies of the specification together with photocopies of
the drawings, if any, can be obtained from the Patent Office, Calcutta or the
concerned branch office on payment of the prescribed fees. One would like to
oppose if the idea of the accepted application infringes upon one's
invention/existing patent, if the coverage of the proposed patent is very wide
which may be detrimental to one's research or if the idea is not novel and so
on.
The Government fee for filing a patent
application (complete/provisional) in India is Rs.750/- for individuals and
Rs.3,000/- for legal entities. An applicant is now required to make a request
for examining the patent application within 48 months of filing of the
application. In case of applications filed before May 20, 2003 examination
request has to be made within the 48 months of filing of the application or
within 12 months from May 20, 2003 whichever is shorter. An individual has to
pay Rs.1,000/- as examination fee and Rs.3,000/- for legal entities. A sealing
fee of Rs.1,500/- for individuals and Rs.5,000/- for legal entities has to be
paid at the time of grant (sealing) of patent.
The law does not require that the information
disclosed in the patent specification be sufficient for commercial exploitation
of the invention. Thus, patent usually will not disclose sufficient information
for commercialization. Know how on the other hand, covers all information
necessary to commercialize the invention e.g. setting up a production plant.
Such information would include, for example, details of the production methods,
the design drawings etc. It is this know how which is traded while transferring
technology. Know how is always kept as a trade secret and not shared with
public. Know how is not protected through patents as most of it is
non-patentable matter and one does not take patent on the remaining parts to
avoid public disclosure. A know how developed around an existing patent and
commercialized subsequently may be an infringement of the patent unless the
patentee has agreed to commercialization on mutually agreed terms.
No. There is nothing like a global patent or a
world patent. Patent rights are essentially territorial in nature and are
protected only in a country (or countries) which,has (have) granted these
rights. In other words,-for obtaining patent rights in different countries one
has to submit patent applications in all the countries of interest for grant of
patents. This would entail payment of official fees and associated expenses,
like the attorney fees, essential for obtaining patent rights in each country.
However, there are some regional systems where by filing one application one
could simultaneously obtain patents in the member countries of a regional
system; European Patent Office is an example of a similar system.
Each country is free to grant or refuse a patent
on the bases of scrutiny by its patent office. This means that granting a
patent in one country of the Union does not force other countries to grant the
patent for the same invention. Also, the refusal of the patent in one country
does not mean that it will be terminated in all the countries.
what
is 'mail box' provision?
TRIPS requires that countries, not providing
product patents in respect of pharmaceuticals and chemical inventions have to
put in a mechanism for accepting product patent applications w.e.f. 1 January
1995. Such applications will only be examined for grant of patents, after
suitable amendments in the national patent law have been made. This mechanism
of accepting product patent applications is called the "mail box" mechanism.
TRIPS requires that member countries of the WTO
not having provision in their laws for granting product patents in respect of
drugs and agrochemical, must introduce Exclusive Marketing Rights (EMR) for
such products, if the following criteria are satisfied:
1. A patent application
covering the new drug or agrochemical should have been filed in any of the WTO
member countries after 1 January, 1995;
2. A patent on the product
should have been obtained in any of the member countries (which provides for
product patents in drugs and agrochemical) after 1 January 1995;
3. Marketing approvals for
the product should have been obtained in any of the member countries;
4. A patent application
covering the product should have been filed after 1 January 1995 in the country
where the EMR is sought;
5. The applicant should
apply seeking an EMR by making use of the prescribed form and paying requisite
fee.
EMR is only a right for exclusive marketing of
the product and is quite different from a patent right. It is valid up to a
maximum period of 5 years or until the time the product patent laws come into
effect.
Yes. The necessary amendment to: the Patents
Act, 1970 came into force on 26 March 1999. The provision is applicable with
retrospective effect from 1 January 1995.
Industrial property includes:
(a) Patents (b) Utility
models (c) Industrial designs (d) Trademarks, service marks and trade names (e)
Indication of source or appellations of origin (this is same as the geographical
indications adopted in TRIPS);
What is the Paris Convention?
The Paris Convention is an international
convention for promoting trade among the member countries, devised to
facilitate protection of industrial property simultaneously in the member
countries without any loss in the priority date. All the member countries
provide national treatment to all the applications from the other member
countries for protection of industrial property rights. The Convention was
first signed in 1883. Since then, the Convention has been revised several
times, in 1900 at Brussels, in 1911 at Washington, in 1925 at the Hague, in
1934 at London, in 1958 at Lisbon and in 1967 at Stockholm. The last amendment
took place in 1979. mdia became a member of the Paris Convention on December 7,
1998. (Readers may note the use of the phrase 'Industrial Property' and
not Intellectual Property).
The principal features of the Paris Convention
have been listed below
- National treatment
- Right of priority
- Independence of patents
- Parallel importation
- Protection against false indications and unfair
competition
This is a very important concept and is
essential for successfully achieving the fundamental aim of the Paris
Convention. The idea is to provide equal treatment to applications from member
countries, in a given member country and not to differentiate between the
nationals of your country and nationals of the other countries for the purpose
of grant, and protection of industrial property in your country. Imagine that a
national of country X applies for grant of a patent in India. According to the
Paris Convention, the Indian Patent Office shall apply the same norms and rules,
to the applicant from X, as applicable to an Indian applicant, for granting a
patent. Similarly the applicant from X shall have the same protection after
grant and identical legal remedies against any infringement shall be available
to the applicant provided the conditions and formalities imposed upon Indians
are complied with. No requirement as to domicile or establishment in the
country where protection is claimed, may. be imposed.
What
do you understand by the right of priority and what is its
significance?
The date from which patent right is deemed to
start is usually the date of filing of complete specification. To obtain rights
in other member countries, the application must be filed on the same day in
other member countries if it is desired to have the rights started from the
same day. However, there are practical difficulties in synchronizing the
activities. For facilitating simultaneous protection in member countries, the
Convention provides that within 12 months of national filing, if patent
applications are filed in those member countries, the patents, if granted in
member countries, will be effective from the date of national filing. This
right is known as the right of priority. In other words you maintain the
priority or the same date of filing in all the member countries and no one else
in those countries can obtain the patent rights on a similar/identical
invention from the same or a later date.
In case the applicant after a second look at the
patent application finds that the patent contains more than one invention or on
his own accord wishes to divide the application, he can claim the initial date
of priority for subsequent patent applications. The applicant may also, on his
own initiative, divide a patent application and preserve as the date of each
divisional application the date of the initial application and the benefit of
the right of priority, if any. Each country of the Union shall have the right
to determine the conditions under which such division shall be authorized.
Priority may not be refused on the ground that
certain elements of the invention for which priority is claimed do not appear
among the claims formulated in the application in the country of origin,
provided that the application documents as a whole specifically disclose such
elements.
Importation is considered as working of patent,
provided the patented product is manufactured in a member country and is
imported into another member country which has also granted a patent on the
same invention to the same applicant. Imagine that a product X has been
patented in two member countries A and B. The product X is then manufactured in
country A and imported into the country B. This product X shall enjooy the same
patent protection in the country B even though it has been manufactured in the
country A. This would also be considered as if the patent has been worked in
country B.
Yes, each member country shall have the right to
provide for the grant of compulsory licenses to prevent the abuses resulting
from the exclusive rights conferred by the patent. Compulsory licenses for
failure to work or insufficient working of the invention may not be requested
before the period of time of non-working or insufficient working has elapsed.
This time limit is four years from the date of filing of the patent application
or three years from the date of the grant. Such licenses will be a
non-exclusive and non-transferable one.
It has been made mandatory for the member
countries of the TRIPS Agreement to comply with the Article 1 to 12 and Article
19 of the Paris Convention.
There are a number of international conventions
and treaties, which are open only to the members of the Paris Convention. Some
of these are:
- Patent Cooperation Treaty (PCT)
- Budapest Treaty (for deposition of microorganisms)UPOV
(for protection of new varieties of plants)
- Madrid Agreement (for repression of false or deceptive
indications of source on goods)
- Madrid Protocol (concerning registration of marks)
- Hague Agreement (concerning deposits of industrial
designs)
This is an international convention governing
the recognition of deposits in officially approved culture collections for the
purpose of patent applications in any country that is a party to it. Because of
the difficulties and on occasion of virtual impossibility of reproducing a
microorganism from a description of it in a patent specification, it is
essential to deposit a strain in a culture collection centre for testing and
examination by others. The Treaty was signed in Budapest in 1973 and later on
amended in 1980. India has become a member of this Treaty, with effect from
December 17, 2001.
An inventor is required to deposit the strain of
a microorganism in a recognized depository which assigns a registration number
to the deposited microorganism. This number needs to be quoted in the patent
application. Obviously a strain of microorganism is required to be deposited
before filing a patent application. It may be observed that this mechanism
obviates the need of describing a microorganism in the patent application.
Further, samples of strains can be obtained from the depository for further
working on the patent. There are many international depositories in many
countries, which are recognized under the Budapest Treaty.
The Indian Patent Act has no specific provision
for patenting of microorganisms and microbiological processes. However, as a
matter of practice microorganisms per se are not patentable in India. (However,
a recent decision of the Kolkata High Court has held that microbiological
processes are patentable in India). In order to meet the obligation under
TRIPS. India is required to introduce a patenting of microorganisms. Draft laws
in this regards have been formulated. It may, however, be noted that many
countries allow both process and product patents in regard to microbiological
inventions and microorganism per se. all such countries allow patenting of
genetically modified microorganisms but a few also allow patenting of naturally
occurring microorganisms if isolated from nature for the first time and if
other conditions of patentability are satisfied.
The patent cooperation treaty (PCT) is a
multilateral treaty entered into force in 1978. Through PCT, an inventor of a
member country (Contracting state of PCT can simultaneously obtain priority for
his/her Invention in all/ any of the member countries, without having to file a
separate application in the countries of interest , by designating them in the
PCT application .India joined the PCT on December 7, 1998.
All activities related to PCT are coordinated by
the World Intellectual Property Organization (WIPO) situated in Geneva.
In order to protect your invention in other
countries, you are required to file an independent patent application in each
country of interest; in some cases , within a stipulated time to obtain
priority in these countries .This would entail a large investment, within a
short time, to meet costs towards filing fees, translation, attorney charges
etc. In addition you are making an assumption which, due to the short time
available for making the decision on whether to file a patent application in a
country or not , may not be well founded .
Inventors of Contracting States of PCT on the
other hand can simultaneously obtain priority for their inventions without
having to file separate application in the countries of interest ; thus saving
the initial investments towards filing fees, translation etc. In addition the
system provides much longer time for filing patent application in member
countries . The time available under Paris Convention for securing priority in
other countries is 12 months from the date of initial filing. Under the PCT,
the time available could be as much as minimum 20 and maximum 31 months.
Further, an inventor is also benefited by the search report prepared under the
PCT system to be sure that the claimed invention is novel. The inventor could
also opt for preliminary examination before filing in other countries to be
doubly sure about the patentability of the invention.
The patent office or nay other office designated
by each contracting state becomes a receiving office for receiving patent
applications These applications are referred to International Searching
Authorities (ISA) which usually the patent offices, appointed to carry out the
patent search on a global basis. In case the receiving office is also an ISA, a
separate referral is not required . There is also a provision to get a patent
application examined by international preliminary Examining Authorities which,
in most cases are ISA.
A search report on the patent application filed
with a receiving office is received by the applicant/inventor 16 months after
the priority date which is nothing but the date of submitting the application
in the receiving office. The International Bureau of the WIPO publishes the
application and the search report 18 months after the priority date. The
original application is then sent to the designated offices indicated in the
application. Within two months of this i.e. by the 20th month,
the applicant will have to formally apply to the patent offices of these
countries for grant of patents by paying official fees and completing other
formalities stipulated by these offices (some countries). In case translated
copies of the application are required, the same has to be furnished by the
applicant. Inspite of submitting the request for grant of patents in designated
countries in the 20th month after the priority date, the
priority in these countries is the same as the date of filing the original PCT
application.
If applicant/inventor has requested for an
examination report, the report is usually received by the applicant /inventor
about 28 months after the priority date. Within two months of this, the
applicant/inventor will have to formally apply for grant of patents in
designated countries .The priority of the application is maintained in the
designated countries.
(a) By the end of the 20th to 31st month
the applicant is in a better position to assess the quality of the invention
being protected as a detailed search report or an examination report or both
would be available to help making an assessment.
(b) Applicants can re-evaluate their decision
about filing applications in all the designated countries after a long gap of
20 to 31 months.
(c ) If not satisfied, applicants may decide to
drop a few countries from the list. This decision would also be influenced by
the changing market conditions.
(d ) Applicants can delay their investment in
respect of the national phase or the regional phase applications by 20 to 31
months without sacrificing priority.
An international application can be filed in any
of the Branch Offices of the Patent Office located at New Delhi, Chennai,
Mumbai and Kolkata (Head Office). Any of these Offices shall function as
receiving office, designated office and elected office for the purpose of
international applications filed under the Treaty.
An international application shall be filed in
the Patent Office which would process the application in accordance with these
rules and the provision under the PCT.
Yes, an international application designating
India shall be treated as an application for patent under the Act.
The schedule of fees is given below for filing
with International Bureau directly:
1. (a) Basic fee up to 30 sheets of a patent application
|
650 Swiss francs
|
(b) Basic fee for a patent application having more than 30
sheets;
|
650 Swiss francs plus
15 Swiss francs for each sheet in excess of 30 sheets |
2. (a) Designation fee if designation is less than 5 (Countries)
|
140 Swiss francs per
designation
|
(b) Designation fee if designation is more than 5 (Countries)
|
700 Swiss francs
|
3. Handling fee
|
233 Swiss francs
|
4. Search fees are additionally payable
5 All fees payable are reduced by 75% for
applications filed by any applicant who resides in a PCT Contracting State
where the per capita national income is below 3000 US dollars. If there are
several applicants, each must satisfy the criterion. It may be noted that no
concessions are available in the national phase or regional phase applications;
respective fees in these phases will have to be paid by the applicant.
All types of fees are payable at the receiving
office and it is the responsibility of the receiving office to remit the search
fees to the concerned office if the receiving office is not the search authority.
Similarly, all other charges due to other agencies, would be remitted by the
receiving office. The fees are payable in the currency acceptable to the
receiving office as an Indian you can pay all the fees in Indian rupees.
New plant varieties cannot be protected in India
at present. However, in many countries such plants can be protected through
Breeders Rights, patent and UPOV Convention India is under an obligation to
introduce a system for protecting new plant variety. The protection can be
through patent or a sui generis system or a combination of these two systems.
UPOV is an abbreviation of Union Pour la
Protection des Obtentionsw Vegetable (Union for protection for new varieties of
plant). It is an international convention which provides a common basis for the
examination of plant varieties in different member States of UPOV for
determining whether a plant variety merits protection under UPOV or not.
There are 5 main criteria to arrive at a
decision whether a plant variety is really new or not. These have remained
unchanged between 1978 and 1991 Acts of the Convention. These criteria are:
1. Distinctness: The variety shall be
deemed to be distinct if it is clearly Discountable from any other variety
whose existence is a matter of common knowledge at the time of filing of the
application .The object of this criterion is to ensure that the candidate
variety can be identified amongst all other varieties whose existence is known,
whether or not they are protected. An application for protection or for the
entry of a variety in an official register in any country causes the variety to
be recorded as a matter of common knowledge. In other words, the application
for the protection should be filed with UPOV before disclosing it to any other
agency.
2. Uniformity: The variety shall be
deemed to be uniform if, subject to the variation that may be accepted from the
particular features of its propagation, it is sufficiently uniform in its
relevant characteristics. .The objective of this criterion is to ensure that
the individuals representing the variety which is a candidate of protection,
form a group which is identifiable on the basis of the description of its
characteristics. In other words, the variation between individuals within a
variety must be less than that within a species. In the absence of this
condition it would become impossible to identify distinct varieties within
species.
The degree of uniformity is determined taking
into account the mode of reproduction of the species and all the genetic
structure of varieties. The same levels of uniformity cannot be required for a
strictly self pollinating species or for a species which is vegetatively
propagated. An acceptable level of uniformity would ensure that it can be used
for agricultural production. In this regard the difference between the
protection, given by UPOV and patent system can be noted.
3. Stability: The variety shall be
deemed to be stable if its relevant characteristics remain unchanged after
repeated propagation or, in the case of a particular cycle of propagation at
the end of each such cycle. The idea is to ensure that the variety will be
identical to the description established at the moment of granting protection
after repeated propagation.
Stability, as well as uniformity may be lost if
the rights holder fails to maintain the variety true to the description
established when the rights were. granted.
4. Novelty: The variety shall be
deemed to be new if, at the date of filing of the application for breeders
right, propagating or harvesting material of the variety has not been sold or
otherwise disposed of to others, by or with the consent of the breeder for the
purpose of exploitation of the variety. It is also understood that a variety to
which people have had free access in the past cannot be protected because then
the interest of those w,ho have relied on the free access, will suffer.
As it is some time necessary to see the response
of the market to new varieties before deciding whether or not to apply for
protectioll, grace period has been included. The period is one year prior to
the date of application in the country where the application is filed and in
countries other than that in which the application has been filed and six years
in case of trees and vines and four years for all other species.
5. Appropriate denomination: The variety shall be
designated by a denomination which will be its generic designation. The premise
that the variety denomination must be its generic designation class for a
requirement that 'denomination must enable the variety to be identified'. Users
and consumers need to have some method of knowing that a sample is a sample of
a particular identified plant variety; because it is often not possible to
identify it from its appearance. This is facilitated by requiring that a
specific denomination and only that denomination be used to identify a variety
in trade.
Yes, India has enacted the New Plant Variety and
Farmers Rights
Protection Act in 2001 which, in addition to
meeting the technical features of UPOV, provides rights to farmers to use the
seeds from their own crops for planting the next crop. Further, there are
provisions for benefit sharing with farmers and penalty for marketing spurious
propagation material.